PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appointment of Ann Marie Dunne, Global Head of R&D Quality and Compliance at Biogen, as its [...]
IMPALA Consortium at DIA 2025 The Drug Information Association (DIA) Global Annual Meeting held in Washington, DC from June 15-19, 2025, brought together pharma industry pioneers, regulatory experts, and healthcare visionaries. The IMPALA (Inter coMPany quALity Analytics) consortium had a [...]
As we wrap up 2024, the IMPALA Consortium reflects on a year of significant progress and achievements in its mission to transform quality in biopharma through the implementation of advance analytics. This year has been marked by impactful work products, [...]
IMPALA is pleased to share it's newest published article in RQA QUASAR #169, November 2024 - Transforming Trial Audits: A Deep Dive Into Data-Driven Clinical Site Audit Selection in Pharmaceuticals. The paper was led by the Audit Site Selection Work Product [...]
IMPALA Consortium is pleased to release the recording from the Research Quality Association (RQA) Quality Conversation session on August 27, 2024. The session highlights include an introduction to IMPALA Consortium and its innovative open-source tools, an in-depth review of the [...]
